ABSTRACT
Over half of veterans diagnosed with OUD have experienced an overdose leading to hospitalization or death. Naloxone is an opioid receptor antagonist that reverses the effects of opioid overdose. Telephone outreach improves naloxone access in high-risk populations. In June 2022, 47.37% of at-risk veterans in an outpatient facility were prescribed naloxone which was significantly lower than the 65.10% national average of other facilities. The nurse-led intervention team implemented the telephone outreach from June 7, 2022, to September 7, 2022. The naloxone prescription rate for veterans diagnosed with OUD in the facility increased from 47.37% in June 2022 (n = 19) to 82.35% in September 2022. The rate for at-risk veterans increased from 20.0% in June 2022 (n = 90) to 58.24% in September 2022. The telephone outreach exceeded goals and increased the naloxone prescription rates for at-risk veterans at the facility in three months.
